Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1558920
Name of medicinal product: XALUPRINE
Active substances:
Mercaptopurine
Estonian, English, Latin
ATC code: L01BB02
Dosage form: oral suspension
Route of administration: oral use
Strengh: 20mg 1ml
Amount in package: 100ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information: annustamissüstal 2 TK
Indication: Xaluprine is indicated for the treatment of acute lymphoblastic leukaemia (ALL) in adults, adolescents and children.
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Last imported to Estonia: October 29, 2019
Marketing authorization holder: Nova Laboratories Ireland Limited 
Marketing authorization number: EU/1/11/727 
Marketing authorization issued on: March 9, 2012 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: February 13, 2019
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere